Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.78
-0.14-3.57%
Last update: Oct 5, 9:29 AM
$4.01
0.092.3%
Molecular Partners AG (MOLN) Stock Price, Quote, News & History
MOLNNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Molecular Partners (NASDAQ:MOLN) through any online brokerage.
Other companies in Molecular Partners’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Molecular Partners has a consensus price target of $9.58.
The stock price for Molecular Partners (NASDAQ: MOLN) is $4.01 last updated October 5, 2026 at 9:29 AM EDT.
There are no upcoming dividends for Molecular Partners.
Molecular Partners does not have any upcoming earnings scheduled.
There is no upcoming split for Molecular Partners.
Molecular Partners is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
